Molecular Genetics, Biochemistry and Clinical Aspects of Inherited Disorders of Purine and Pyrimidine Metabolism 1993
DOI: 10.1007/978-3-642-84962-6_3
|View full text |Cite
|
Sign up to set email alerts
|

The Biochemical Basis of HGPRT Deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2001
2001
2014
2014

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…7 Affected individuals have hyperuricemia and a characteristic neurobehavioral phenotype comprising mental retardation, self-injurious behaviour and motor disability. [9][10][11] In addition, patients present a prominent loss of striatal dopamine. [9][10][11] In addition, patients present a prominent loss of striatal dopamine.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…7 Affected individuals have hyperuricemia and a characteristic neurobehavioral phenotype comprising mental retardation, self-injurious behaviour and motor disability. [9][10][11] In addition, patients present a prominent loss of striatal dopamine. [9][10][11] In addition, patients present a prominent loss of striatal dopamine.…”
Section: Introductionmentioning
confidence: 99%
“…8 A common factor in Lesch-Nyhan is that patients exhibit a characteristically raised level of hypoxanthine in the urine, 9 plasma and cerebrospinal fluid. [9][10][11] In addition, patients present a prominent loss of striatal dopamine. 12 Bavaresco and colleagues 13,14 demonstrated that the in vitro administration of hypoxanthine induces oxidative stress in the striatum of rats and that intrastriatal injection alters striatal ectonucleotidase activities.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, patients present a prominent loss of striatal dopamine (Jinnah and Friedmann, 2001). A common factor in Lesch–Nyhan is that patients exhibit a characteristically raised level of hypoxanthine in urine (Harkness et al, 1988), plasma and cerebrospinal fluid (Rosenbloom et al, 1967; Harkness et al, 1988; Puig and Mateos, 1993). Although the underlying mechanisms of brain dysfunction in Lesch–Nyhan are poorly understood, the accumulation of oxypurines such as hypoxanthine has been proposed to contribute to the neurological dysfunction present in this disease (Dasheiff, 1980; Kisch et al, 1985; Visser et al, 2000; Ma et al, 2001).…”
Section: Introductionmentioning
confidence: 99%